Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Quick Stats
Jun 22, 202661.3
AI Score
BUY0.87
Volume Ratio
Aug 12, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
ELVN Stock Summary
Last updated Jun 22, 2026
ELVN is currently trading at $45.99, positioned above its 200-day moving average of $28.35, indicating a long-term uptrend. The stock has a 52-week range of $14.785 to $48.53.
Technical Analysis: The 50-day moving average stands at $41.76, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.156, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.084, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ELVN at 61.3/100 with a BUY recommendation.
ELVN (Enliven Therapeutics, Inc. Common Stock) Indicators
Last updated Jun 22, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.156 |
| CMF (20) | -0.084 |
| ROC (10) | 33.276 |
| ADX (14) | 27.199 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.206 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -14.997 |
| MFI (14) | 66.781 |
ELVN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ELVN Price vs Max Options Open Interest
ELVN Max Change In Options Open Interest
ELVN Options - Sort by Max open Interest (near term)
22nd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ELVN Daily Out of Money Options - Sort by Max open Interest (near term)
22nd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ELVN Daily In the Money Options - Sort by Max open Interest (near term)
22nd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ELVN Most Active Options by Volume(near term)
22nd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Enliven Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
ELVN Moving Averages Analysis
Enliven Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 22, 2026
Enliven Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 22, 2026
ELVN (Enliven Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 22, 2026
| Days | MA |
|---|---|
| 10 | 41.41 |
| 20 | 39.95 |
| 30 | 40.45 |
| 50 | 41.76 |
| 100 | 36.27 |
| 200 | 28.35 |
ELVN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.1 billion |
| Earnings/Share ($) | -1.64 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.75 |
| EPS Estimate Next Year ($) | -2.43 |
| WallStreet Target Price ($) | 60.1111 |
| Most Recent Quarter |